In the following video, Motley Fool health-care bureau chief Brenton Flynn continues his look at UnitedHealth Group's (UNH -4.82%) annual 10-K report and highlights three important takeaways that investors need to be aware of. He discusses an international expansion for the company with its acquisition of Amil in Brazil, tells us about some wording in the 10-K implying that the company might exit certain states if regulations become too stringent there, and gives us some broader pricing trends affecting both UnitedHealth's commercial and government businesses.
You're reading a free article with opinions that may differ from The Motley Fool's Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
UnitedHealth's Annual Checkup
NYSE: UNH
UnitedHealth Group

Time to take UnitedHealth to the doctor and see how it's doing this year.
Brenton Flynn has no position in any stocks mentioned. The Motley Fool recommends UnitedHealth Group. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Stocks Mentioned


*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.
Related Articles





Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.